sodium (6R-trans)-7-amino-8-oxo-3-[[[1-(sulfomethyl)-1H-tetrazol-5-yl]thio]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate monohydrate
See how the hazards of sodium (6R-trans)-7-amino-8-oxo-3-[[[1-(sulfomethyl)-1H-tetrazol-5-yl]thio]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate monohydrate combine into label elements for your jurisdiction (EU CLP, GB CLP, OSHA HazCom) — the correct pictograms, signal word and H-statements, with CLP Article 26 precedence applied and explained.
Handling and Storage Guidance for sodium (6R-trans)-7-amino-8-oxo-3-[[[1-(sulfomethyl)-1H-tetrazol-5-yl]thio]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate monohydrate
sodium (6R-trans)-7-amino-8-oxo-3-[[[1-(sulfomethyl)-1H-tetrazol-5-yl]thio]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate monohydrate may cause irritation to skin, eyes, or respiratory tract, or has low-level systemic toxicity. Adequate ventilation must be provided in work areas. Personal protective equipment (gloves, eye protection) is recommended during handling.
This information is provided for reference only. Always consult the official Safety Data Sheet (SDS) and applicable national regulations before handling this substance.
The GHS classification shown above for sodium (6R-trans)-7-amino-8-oxo-3-[[[1-(sulfomethyl)-1H-tetrazol-5-yl]thio]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate monohydrate corresponds to Section 2 of its Safety Data Sheet. Learn how a compliant 16-section SDS is structured and authored.